Interleukin-21 engineering enhances NK cell activity against glioblastoma via CEBPD
Mayra Shanley, May Daher, Jinzhuang Dou, Sufang Li, Rafet Başar, Hind Rafei, Merve Dede, Joy Gumin, Jezreel Pantaleόn Garcίa, Ana Karen Nunez Cortes, Shan He, Corry M. Jones, Sunil Acharya, Natalie W. Fowlkes, Donghai Xiong, Sanjay K. Singh, Hila Shaim, S. Hicks, Bin Liu, Abhinav K. Jain, Mohammed Fayyad Zaman, Qi Miao, Ye Li, Nadima Uprety, Enli Liu, Luis Muniz-Feliciano, Gary Deyter, Vakul Mohanty, Patrick Zhang, Scott E. Evans, Elizabeth J. Shpall, Frederick F. Lang, Ken Chen, Katayoun Rezvani
Topics & Concepts
ReprogrammingCancer researchInterleukin 12BiologyInterleukin 21Interleukin 15Cytotoxic T cellImmune systemCellImmunologyInterleukinT cellIn vitroCytokineBiochemistryImmune Cell Function and InteractionCAR-T cell therapy researchT-cell and B-cell Immunology